98 related articles for article (PubMed ID: 30783036)
1. Malignancy-Associated Hypercalcemia Related with Receptor Activator of NF-κB Ligand (RANKL) Expression in T-Cell Acute Lymphoblastic Leukemia.
Tahara K; Koiso H; Osaki YH; Sekigami T; Yokohama A; Saitoh T; Tsukamoto N; Murakami H; Abe M; Handa H
Acta Haematol; 2019; 141(3):135-137. PubMed ID: 30783036
[No Abstract] [Full Text] [Related]
2. High ENT1 and DCK gene expression levels are a potential biomarker to predict favorable response to nelarabine therapy in T-cell acute lymphoblastic leukemia.
Akahane K; Murakami Y; Kagami K; Abe M; Harama D; Shinohara T; Watanabe A; Goi K; Nishi R; Yamauchi T; Kimura S; Takita J; Look AT; Minegishi M; Sugita K; Inukai T
Hematol Oncol; 2019 Oct; 37(4):516-519. PubMed ID: 31335977
[No Abstract] [Full Text] [Related]
3. Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset.
Nagel S; Meyer C; Kaufmann M; Zaborski M; MacLeod RAF; Drexler HG
PLoS One; 2018; 13(5):e0197194. PubMed ID: 29746601
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia.
Okada Y; Tsukada J; Nakano K; Tonai S; Mine S; Tanaka Y
J Bone Miner Res; 2004 Jul; 19(7):1105-11. PubMed ID: 15176993
[TBL] [Abstract][Full Text] [Related]
5. Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillance.
Schmiedel BJ; Nuebling T; Steinbacher J; Malinovska A; Wende CM; Azuma M; Schneider P; Grosse-Hovest L; Salih HR
J Immunol; 2013 Jan; 190(2):821-31. PubMed ID: 23241893
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
7. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein.
Harutsumi M; Akazai A; Kitamura T; Manki A; Tanaka H; Oda M; Seino Y
Miner Electrolyte Metab; 1995; 21(1-3):171-6. PubMed ID: 7565443
[TBL] [Abstract][Full Text] [Related]
8. ETP-ALL with aberrant B marker expression: Case series and a brief review of literature.
Garg S; Gupta SK; Bakhshi S; Mallick S; Kumar L
Int J Lab Hematol; 2019 Apr; 41(2):e32-e37. PubMed ID: 30407727
[No Abstract] [Full Text] [Related]
9. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia/lymphoma: molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-I-infected T cells.
Ikeda K; Inoue D; Okazaki R; Kikuchi T; Ogata E; Matsumoto T
Miner Electrolyte Metab; 1995; 21(1-3):166-70. PubMed ID: 7565442
[No Abstract] [Full Text] [Related]
11. Multiple myeloma/hypercalcemia.
Oyajobi BO
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
[TBL] [Abstract][Full Text] [Related]
12. TRIB2 reinforces the oncogenic transcriptional program controlled by the TAL1 complex in T-cell acute lymphoblastic leukemia.
Tan SH; Yam AW; Lawton LN; Wong RW; Young RA; Look AT; Sanda T
Leukemia; 2016 Apr; 30(4):959-62. PubMed ID: 26202930
[No Abstract] [Full Text] [Related]
13. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection.
Miller RE; Branstetter D; Armstrong A; Kennedy B; Jones J; Cowan L; Bussiere J; Dougall WC
J Immunol; 2007 Jul; 179(1):266-74. PubMed ID: 17579046
[TBL] [Abstract][Full Text] [Related]
15. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
Lei J; Li Q; Gao Y; Zhao L; Liu Y
Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
[TBL] [Abstract][Full Text] [Related]
16. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge.
Li N; Wang SA; Lin P; Jabbour E; Thompson P; Chen Z; Li S; Xu J; You MJ; Bueso-Ramos CE; Medeiros LJ; Yin CC
Am J Hematol; 2019 Sep; 94(9):1049-1051. PubMed ID: 30916805
[No Abstract] [Full Text] [Related]
17. RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
Jenkins CE; Gusscott S; Wong RJ; Shevchuk OO; Rana G; Giambra V; Tyshchenko K; Islam R; Hirst M; Weng AP
Exp Hematol; 2018 Aug; 64():84-96. PubMed ID: 29733873
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia with nephrocalcinosis and impaired renal function due to increased Parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia.
Lankisch P; Kramm CM; Hermsen D; Wessalowski R
Leuk Lymphoma; 2004 Aug; 45(8):1695-7. PubMed ID: 15370228
[TBL] [Abstract][Full Text] [Related]
19. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
20. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
